Cite
HARVARD Citation
Loomba, R. et al. (n.d.). Obeticholic acid demonstrates sustained improvements at month 24 in transaminases and non-invasive markers of fibrosis: Results of a post hoc analysis from the interim analysis of the REGENERATE study. Digestive and liver disease. pp. S26-. [Online].